These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 12557460)

  • 1. Speech pathology & Parkinson's disease in the home environment.
    Regnell ME
    Caring; 2003 Jan; 22(1):20-2. PubMed ID: 12557460
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Speech disorders in Parkinson patients].
    Kerschan K; Pankl W; Auff E
    Wien Klin Wochenschr; 1998 Apr; 110(8):279-86. PubMed ID: 9615959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Guidelines for the delivery of speech-language pathology and audiology services in home care.
    ASHA; 1990 Sep; 32(9):67-70, 66. PubMed ID: 2222567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Speech treatment for Parkinson's disease.
    Ramig LO; Fox C; Sapir S
    Expert Rev Neurother; 2008 Feb; 8(2):297-309. PubMed ID: 18271714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Home-based speech treatment for Parkinson's disease delivered remotely: a case report.
    Constantinescu GA; Theodoros DG; Russell TG; Ward EC; Wilson SJ; Wootton R
    J Telemed Telecare; 2010; 16(2):100-4. PubMed ID: 20008051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Communication services in home health care agencies: availability and scope.
    Lubinski R; Chapey R
    ASHA; 1980 Nov; 22(11):929-34. PubMed ID: 7004448
    [No Abstract]   [Full Text] [Related]  

  • 7. Progression of dysprosody in Parkinson's disease over time--a longitudinal study.
    Skodda S; Rinsche H; Schlegel U
    Mov Disord; 2009 Apr; 24(5):716-22. PubMed ID: 19117364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parkinson's disease: speech and voice disorders and their treatment with the Lee Silverman Voice Treatment.
    Ramig LO; Fox C; Sapir S
    Semin Speech Lang; 2004 May; 25(2):169-80. PubMed ID: 15118943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Behavioral treatments for speech in Parkinson's disease: meta-analyses and review of the literature.
    Atkinson-Clement C; Sadat J; Pinto S
    Neurodegener Dis Manag; 2015; 5(3):233-48. PubMed ID: 26107322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-drug therapies are highly beneficial in Parkinson's disease, but seldom prescribed.
    Healthc Demand Dis Manag; 1998 Aug; 4(8):122-6. PubMed ID: 10182914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maximizing your investment: Recruitment and retention of speech-language pathologists in home care.
    Hasselkus A
    Caring; 2006 Sep; 25(9):16-9. PubMed ID: 17022318
    [No Abstract]   [Full Text] [Related]  

  • 12. The status of speech-language pathology in the home health setting.
    Hester EJ
    ASHA; 1981 Mar; 23(3):155-62. PubMed ID: 7016125
    [No Abstract]   [Full Text] [Related]  

  • 13. The science and practice of LSVT/LOUD: neural plasticity-principled approach to treating individuals with Parkinson disease and other neurological disorders.
    Fox CM; Ramig LO; Ciucci MR; Sapir S; McFarland DH; Farley BG
    Semin Speech Lang; 2006 Nov; 27(4):283-99. PubMed ID: 17117354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of intensive voice treatment on tone-language speakers with Parkinson's disease.
    Whitehill TL; Wong LL
    Clin Linguist Phon; 2007; 21(11-12):919-25. PubMed ID: 17972188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of intensive voice treatment (the Lee Silverman Voice Treatment [LSVT]) on vowel articulation in dysarthric individuals with idiopathic Parkinson disease: acoustic and perceptual findings.
    Sapir S; Spielman JL; Ramig LO; Story BH; Fox C
    J Speech Lang Hear Res; 2007 Aug; 50(4):899-912. PubMed ID: 17675595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Speech, Voice, and Communication.
    Johnson JA
    Int Rev Neurobiol; 2017; 134():1189-1205. PubMed ID: 28805569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Voice and choral singing treatment: a new approach for speech and voice disorders in Parkinson's disease.
    Di Benedetto P; Cavazzon M; Mondolo F; Rugiu G; Peratoner A; Biasutti E
    Eur J Phys Rehabil Med; 2009 Mar; 45(1):13-9. PubMed ID: 18987565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Speech production in Parkinson's disease: II. Acoustic and electropalatographic investigation of sentence, word and segment durations.
    McAuliffe MJ; Ward EC; Murdoch BE
    Clin Linguist Phon; 2006; 20(1):19-33. PubMed ID: 16393796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studying vocal fold vibrations in Parkinson's disease with a nonlinear model.
    Zhang Y; Jiang J; Rahn DA
    Chaos; 2005 Sep; 15(3):33903. PubMed ID: 16252994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of subthalamic nucleus stimulation on parkinsonian dysarthria and speech intelligibility.
    Rousseaux M; Krystkowiak P; Kozlowski O; Ozsancak C; Blond S; Destée A
    J Neurol; 2004 Mar; 251(3):327-34. PubMed ID: 15015014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.